摘要
目的 分析玻璃酸钠治疗中度膝关节骨性关节炎的远期效果。方法 随机选择2015年1月-2016年12月在本院接受治疗的中度膝关节骨性关节炎患者84例参与研究,随机平均分成2组,对照组42例利用硫酸氨基葡萄糖口服治疗,观察组42例在对照组治疗基础上选择玻璃酸钠治疗,比较2组临床治疗的远期效果。结果 观察组膝关节功能恢复优良率为80.95%,对照组膝关节功能优良率为54.76%,2组差异有统计学意义,P〈0.05;观察组治疗后3个月、治疗后9个月、治疗后1年膝关节功能Lysholm评分结果均明显高于对照组;观察组治疗后3个月、治疗后9个月、治疗后1年生活质量AIMS评分明显低于对照组,差异均有统计学意义。结论 玻璃酸钠治疗中度膝关节骨性关节炎远期疗效明显,能够帮助膝关节功能得到明显改善,促使患者生活质量得到明显提升,值得广泛应用。
Objective To analyze the long term efficacy of sodium hyaluronate on the treatment of moderate knee osteoarthritis. Methods From January 2015 to December2016 year in our hospital , 84 patients with moderate knee osteoarthritis were participated in the study, and were randomly divided into two groups, 42 cases in each group. The control group were given oral glucosamine sulfate . Based on the treatment of the control group, the observation group were received sodium hyaluronate . The long-term effect in the two groups were compared. Results The excellent rate of knee joint function recovery was 80.95% in the observation group, and 54.76% in the control group, the difference in the two groups had statistically significant, P〈0.05; Three months, nine months, and one years after treatment, the knee joint function Lysholm scores in the observation group were significantly higher than those in the control group; Three months, nine months, and one years after treatment, AIMS quality of life score in the observation group was significantly lower than those in the control group. Conclusion The long-term effect of sodium hyaluronate in the treatment of moderate knee osteoarthritis is obvious. It can help the knee joint function to be improved significantly, and promote the quality of life of patients significantly improved. It is worth to be widely applied.
出处
《中国生化药物杂志》
CAS
2017年第8期151-153,共3页
Chinese Journal of Biochemical Pharmaceutics
